Economist, author and financial analyst Peter Schiff told CNBC's Rick Santelli the new tax inversion rules from the Obama administration, which ended the Allergan-Pfizer deal, could backfire.
"By the government making it harder for American companies to buy foreign companies and invert, they are going to leave American companies vulnerable to being acquired by foreign companies instead," Schiff said in a Santelli Extra interview exclusive to CNBC Pro subscribers. "And when that happens, the domestic job losses are going to be much bigger."
Apart from tax regulation, Schiff also discusses his views on inflation, gold, the Fed and Donald Trump.
You can watch his full interview below, but you must be a CNBC Pro subscriber.